Rain Oncology Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Rain Oncology Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$53.05 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2022-11-10
- Rain Oncology Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$18.04M.
- Rain Oncology Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$18.43M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2022-09-30 | -$18.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$53.05M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$35.01M 10-Q · filed 2022-08-04 | ||
| 2021-09-30 | -$18.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$33.41M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$14.98M 10-Q · filed 2022-08-04 |